This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Endocrine pancreas
CD2_BENIGN_ENDOCRINE_PANCREAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum partis endocrinae pancreatis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Endocrine pancreas
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Endocrine pancreas
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 201 | 88 | 113 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | 63.92 | 60.64 | 66.46 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 178
- Matched controls
- 1779
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
+∞
240.8
172
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
142.0
74.1
75
9
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
45.2
34.6
42
12
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
39.1
28.1
35
11
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
33.3
25.5
33
12
JN3BD
NOMESCO Finland
Extensive abdominal CT
9.4
25.4
57
85
WX302
NOMESCO Finland
Thoracal epidural anesthesy
23.4
25.1
36
19
130
Kela drug reimbursment
Malignant tumour
+∞
23.4
22
*
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
261.9
23.2
23
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
21.0
22.3
33
19
JLC10
NOMESCO Finland
Distal pancreatectomy
236.1
21.0
21
*
JN4BD
NOMESCO Finland
Extensive body CT
13.0
20.6
37
35
JN4CD
NOMESCO Finland
Very extensive body CT
37.3
18.5
23
7
JN4AD
NOMESCO Finland
Body CT examination
15.4
18.2
30
23
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
18.0
17
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
18.0
17
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.3
17.3
33
35
A09AA02
ATC
multienzymes (lipase, protease etc.)
19.6
16.1
24
14
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
15.9
15
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
15.9
15
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
174.4
15.7
16
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.8
15.2
88
363
JN3AD
NOMESCO Finland
Abdominal CT examination
7.6
15.0
36
57
JLC00
NOMESCO Finland
Excision of lesion of pancreas
+∞
14.8
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.9
13.8
71
261
WF002
NOMESCO Finland
Radical radiotherapy
+∞
13.7
13
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
28.3
13.7
18
7
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
150.8
13.6
14
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.5
13.3
85
368
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
31.0
13.2
17
6
A03FA01
ATC
metoclopramide; systemic, rectal
5.2
12.9
43
103
K86.2
ICD-10 Finland
Cyst of pancreas
34.8
12.8
16
5
E16.10
ICD-10 Finland
Hyperinsulinism
+∞
12.6
12
*
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
139.2
12.6
13
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
139.2
12.6
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
139.2
12.6
13
*
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
29.0
12.3
16
6
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
50.2
12.1
14
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.1
11.8
33
64
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
11.6
11
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
11.6
11
*
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
11.6
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
11.6
11
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.6
11.2
41
108
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.7
11.0
28
48
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
10.7
98
526
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
10.5
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
H02AB02
ATC
dexamethasone; systemic
20.3
10.4
15
8
ZXE20
NOMESCO Finland
More than three and less than five hours
4.2
10.1
41
119
A04AA02
ATC
granisetron; systemic, transdermal
105.2
9.5
10
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
105.2
9.5
10
*
ZXC96
NOMESCO Finland
Robot assisted procedure
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.6
9.1
23
39
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
9.0
31
76
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
9.0
8.8
18
22
WX402
NOMESCO Finland
General anaesthesia
3.8
8.7
38
117
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
8.7
67
312
L02AE02
ATC
leuprorelin; implant, parenteral
29.1
8.6
11
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
8.6
61
267
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
94.2
8.5
9
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
+∞
8.4
8
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
8.4
8
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
+∞
8.4
8
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
+∞
8.4
8
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.1
8.0
21
38
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
47.0
7.8
9
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
12.6
7.7
13
11
R50.9
ICD-10 Finland
Fever, unspecified
4.0
7.7
31
89
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.9
7.7
32
95
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
7.3
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
115
Kela drug reimbursment
Breast cancer
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
7.3
44
173
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
31.4
7.2
9
*
A02BC02
ATC
pantoprazole; systemic
2.4
6.8
128
914
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
41.6
6.8
8
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
41.6
6.8
8
*
JAH01
NOMESCO Finland
Laparoscopy
9.2
6.7
13
15
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
72.2
6.5
7
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
11.6
6.4
11
10
ZXE00
NOMESCO Finland
One hour or less
2.3
6.4
79
460
UJF32
NOMESCO Finland
Coloscopy
2.5
6.3
56
275
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
H01CB03
ATC
lanreotide; parenteral
+∞
6.3
6
*
V03AH01
ATC
diazoxide; systemic
+∞
6.3
6
*
H01CB02
ATC
octreotide; parenteral
+∞
6.3
6
*
8249/3-C25.9
ICD-O-3
Neuroendocrine tumor, grade 2 of pancreas, NOS
+∞
6.3
6
*
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
27.7
6.3
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
6.2
41
170
UJK02
NOMESCO Finland
ERCP
9.1
6.2
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
80
93
13.63
68.36
3.1
1.5
ug/l
2.9
5.8
0.41
59
67
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
46
38
15.40
47.88
2.3
1.8
u/ml
34.5
10.7
0.49
40
26
(4035726)
48
47
13.10
44.90
1.6
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
37
41
10.83
31.37
1.8
1.2
ug/g
229.1
299.6
0.87
28
24
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
151
710
5.53
27.21
8.0
5.1
mmol/l
1.2
1.2
0.14
143
643
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
124
522
4.59
25.23
3.7
2.2
u/l
60.5
57.8
0.19
118
483
(3024561) Albumin [Mass/volume] in Serum or Plasma
144
683
4.91
24.81
7.3
3.6
g/l
34.6
35.7
1.58
139
639
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
155
791
5.19
23.89
11.0
5.6
mmol/l
1.2
1.2
0.02
121
688
(3018418) pH of Serum or Plasma
113
459
4.34
23.79
4.8
3.4
ph
7.4
7.4
0.18
31
77
(3032080) INR in Blood by Coagulation assay
139
680
4.38
22.00
15.3
10.6
inr
1.3
1.3
0.40
53
190
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
54
149
4.59
18.56
2.7
1.8
u/l
304.7
30.6
0.55
46
122
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
48
127
4.65
17.31
4.6
4.1
ng/l
89.0
85.4
0.11
41
107
(3033658) Prothrombin time (PT) actual/Normal
87
362
3.47
16.35
4.0
3.2
%
91.9
89.4
0.36
87
354
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
22
9.43
15.26
1.6
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
102
486
3.23
15.06
2.4
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
43
117
4.40
14.84
4.4
3.0
mmol/l
1.2
1.2
0.08
36
103
(3013826) Glucose [Moles/volume] in Serum or Plasma
158
983
3.84
14.76
8.0
4.1
mmol/l
7.0
6.9
0.25
152
906
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
23
9.02
14.75
1.4
1.3
nmol/l
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
105
514
3.18
14.72
2.9
2.6
u/l
31.7
30.6
0.09
99
492
(3012095) Magnesium [Moles/volume] in Serum or Plasma
64
233
3.56
14.62
3.1
2.5
mmol/l
0.8
0.8
0.95
64
216
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
123
687
3.04
13.20
5.6
3.7
—
—
—
0
0
(3002256) Pathology report gross observation
40
116
4.06
12.59
1.6
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
92
451
2.92
12.35
3.2
2.7
e6/l
1.5
0.5
0.32
71
326
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
117
653
2.89
12.29
3.1
2.2
nmol/l
82.1
76.9
0.90
110
567
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
109
588
2.87
12.18
3.2
2.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
89
437
2.86
11.80
3.3
2.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
47
164
3.44
11.22
5.2
3.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
48
172
3.35
10.97
2.5
2.3
umol/l
9.6
7.1
0.39
41
151
(3014576) Chloride [Moles/volume] in Serum or Plasma
54
210
3.15
10.77
6.9
5.3
mmol/l
106.4
104.2
3.44
54
202
(3002582) Erythrocytes [#/volume] in Urine
94
496
2.68
10.58
3.4
3.0
e6/l
215.0
61.5
0.46
72
371
(40768800) Prostate Pathology biopsy report
12
13
9.75
9.97
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
13
9.75
9.97
2.3
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
49
189
3.11
9.84
8.2
6.1
kpa
5.1
5.2
0.10
49
183
(3044640) Blood type and Crossmatch panel - Blood
86
452
2.58
9.55
2.9
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
38
129
3.40
9.38
4.8
3.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
48
189
3.02
9.27
8.3
6.1
kpa
14.0
11.5
2.02
48
184
(3031040) Bacteria [#/volume] in Urine by Automated count
151
1062
2.70
8.65
4.9
4.2
—
3619.4
—
0
21
(3015377) Calcium [Moles/volume] in Serum or Plasma
90
501
2.44
8.65
4.7
2.1
mmol/l
2.4
2.3
1.21
84
422
(3025159) Blasts/100 leukocytes in Blood
31
98
3.56
8.51
4.5
4.5
%
0.0
0.1
—
8
19
(3012501) Base excess in Blood by calculation
17
34
5.37
8.30
4.9
3.5
mmol/l
2.8
2.4
0.21
11
18
(3013650) Neutrophils [#/volume] in Blood by Automated count
131
875
2.43
8.18
10.2
6.1
e9/l
4.5
4.3
0.53
118
765
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
47
199
2.78
7.87
3.0
2.7
%
21.8
23.9
0.35
40
173
(3018095) Leukocytes [#/volume] in Urine
98
587
2.31
7.76
4.0
3.5
e6/l
59.9
102.6
0.46
74
409
(3002179) Metamyelocytes/100 leukocytes in Blood
30
99
3.39
7.69
4.6
4.5
%
0.8
0.4
—
8
17
(3023368) Bacteria identified in Blood by Culture
76
412
2.36
7.55
5.5
3.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
102
3.28
7.33
4.8
4.4
%
0.1
0.1
—
9
21
(3010421) pH of Blood
17
39
4.67
7.11
5.3
3.4
ph
7.4
7.4
0.02
17
33
(3020891) Body temperature
24
72
3.65
7.09
4.5
3.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
31
110
3.15
7.06
4.7
4.2
%
0.8
1.1
—
8
24
(40758558) Short blood count panel - Blood
67
357
2.32
6.82
8.3
4.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
28
5.30
6.81
4.8
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
32
4.98
6.81
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
48
222
2.53
6.67
1.6
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
21
6.01
6.67
1.2
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
119
807
2.16
6.57
4.4
3.7
estimate
0.0
0.0
0.00
38
142
(3009261) Glucose [Presence] in Urine by Test strip
119
816
2.12
6.28
4.4
3.7
estimate
0.0
0.0
0.00
36
137
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
95
3.13
6.22
1.9
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
108
719
2.09
6.11
16.2
8.2
e9/l
0.0
0.0
0.03
93
586
(3021601) Nitrite [Presence] in Urine by Test strip
117
806
2.08
5.99
5.9
5.1
estimate
0.0
0.0
0.00
36
139
(3007853) Bacteria identified in Skin by Aerobe culture
42
194
2.47
5.80
1.4
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
50
251
2.32
5.75
2.8
2.8
e6/l
1.1
3.1
1.24
21
131
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
56
300
2.20
5.49
4.1
2.1
mmol/l
2.5
2.4
2.72
50
251
(3003694) ABO and Rh group [Type] in Blood
66
380
2.10
5.38
1.3
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
67
392
2.06
5.21
2.4
2.0
mg/l
3.4
3.1
0.43
62
325
(3009508) Creatinine [Moles/volume] in Urine
90
587
1.97
5.14
3.2
3.2
mmol/l
7.0
7.7
1.06
77
487
(3042936) Bacteria identified in Isolate by Culture
46
233
2.26
5.14
2.3
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
157
2.49
5.12
1.5
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
144
1105
2.07
5.11
5.3
3.0
u/l
68.3
46.4
0.93
137
1027
(3044889) 12 lead EKG panel
154
1212
2.16
5.09
5.4
3.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
84
539
1.96
5.00
5.6
5.0
—
—
—
0
0
(3015736) pH of Urine
95
636
1.94
4.99
3.9
3.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
92
611
1.93
4.93
4.2
4.2
mg/mmol
8.6
6.3
0.21
54
378
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
18
57
3.37
4.90
2.4
1.9
ug/l
8.8
2.7
0.53
18
52
(3012516) Albumin [Mass/volume] in Urine
87
570
1.93
4.83
3.1
3.4
mg/l
59.6
163.2
0.42
51
358
(3042631) Mycobacterium sp identified in Specimen
10
20
5.21
4.83
3.1
3.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
7
11.83
4.82
3.0
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
112
798
1.91
4.82
5.7
4.9
e9/l
0.7
0.6
0.98
101
689
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
75
468
1.96
4.81
1.7
1.6
mmol/l
1.5
1.3
0.72
62
388
(40760892) CBC W Ordered Manual Differential panel - Blood
61
354
2.04
4.80
5.0
3.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
112
803
1.89
4.68
5.7
4.9
e9/l
0.0
0.0
0.05
101
700
(3000991) Gas panel - Venous blood
30
131
2.52
4.63
6.5
7.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
21
76
2.97
4.61
7.8
8.4
mmol/l
23.2
24.9
1.39
21
68
(3019198) Lymphocytes [#/volume] in Blood
112
812
1.86
4.43
5.7
5.0
e9/l
1.9
1.9
0.02
102
718
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
277
2.07
4.42
2.7
2.5
e6/l
1.1
1.1
0.03
22
155
(3013115) Eosinophils [#/volume] in Blood
113
822
1.86
4.42
5.7
5.1
e9/l
0.2
0.2
0.07
102
726
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
100
702
1.84
4.37
4.4
3.8
ng/l
39.7
45.8
0.18
76
512
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
22
4.73
4.35
1.3
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
31
4.05
4.32
4.6
2.9
%
52.5
58.2
0.59
12
31
(3029937) Albumin [Presence] in Urine by Test strip
70
441
1.90
4.28
4.9
3.8
estimate
0.0
0.0
0.00
32
138
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
155
1256
2.02
4.27
4.4
3.7
pmol/l
15.0
15.0
0.02
143
1129
(3026008) Bacteria identified in Urine by Culture
72
462
1.87
4.14
3.6
3.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
10
8.27
4.10
4.0
1.4
ug/l
15.2
12.3
—
8
10
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
167
2.25
4.05
1.9
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
34
167
2.25
4.05
1.9
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
59
3.06
4.01
2.8
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
188
1660
3.05
4.01
25.0
12.4
mg/l
33.1
23.5
2.18
175
1276
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
342
1.93
4.00
3.1
2.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
69
442
1.85
3.96
4.1
3.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
83
2.71
3.94
12.7
8.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
91
635
1.79
3.94
4.9
3.8
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
8
11
7.52
3.89
1.3
1.3
mmol/l
7.3
—
—
8
0
(3037467) Urinalysis macro (dipstick) panel - Urine
143
1147
1.86
3.81
4.8
3.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
30
3.82
3.69
3.6
2.3
e9/l
3.5
4.6
1.09
11
30
(3021960) Folate [Moles/volume] in Serum or Plasma
66
428
1.81
3.59
1.5
1.5
nmol/l
21.1
22.2
0.26
59
365
(3026493) Urate [Moles/volume] in Serum or Plasma
69
455
1.79
3.55
2.3
2.6
umol/l
390.5
8988.3
2.44
54
400
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
78
535
1.75
3.49
2.0
2.1
u/l
177.6
179.7
0.01
72
498
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
53
2.98
3.44
2.2
4.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
25
117
2.30
3.33
11.8
6.0
mmol/l
25.0
24.9
0.04
25
112
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
7
8.79
3.28
2.7
1.1
umol/l
26.7
27.7
—
6
7
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
59
381
1.78
3.22
2.1
1.7
pmol/l
454.8
416.2
0.62
46
309
(3001122) Ferritin [Mass/volume] in Serum or Plasma
91
665
1.67
3.16
3.3
2.7
ug/l
164.4
119.2
0.70
85
607
(3019309) Folate [Moles/volume] in Red Blood Cells
52
325
1.81
3.15
2.5
1.8
nmol/l
1315.2
1238.1
0.22
43
251
(3023520) Reticulocytes [#/volume] in Blood
29
149
2.11
3.09
2.9
2.4
e9/l
60.6
66.6
0.48
24
111
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
29
3.58
3.09
4.4
2.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
25
121
2.22
3.08
8.9
4.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
188
1701
2.63
3.03
6.5
4.8
mmol/l
6.5
6.1
2.14
181
1533
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
42
249
1.87
3.00
2.0
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
5
10.21
2.99
4.2
7.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
176
1557
2.05
2.90
5.2
4.5
mu/l
1.9
1.9
0.13
162
1401
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
36
3.17
2.85
1.3
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
182
1636
2.19
2.77
8.9
6.5
mmol/mol
41.8
40.6
0.89
176
1520
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
15
4.79
2.62
2.6
1.5
u/ml
135.7
249.6
—
7
15
(3023103) Potassium [Moles/volume] in Serum or Plasma
191
1759
2.73
2.62
32.3
15.3
mmol/l
4.0
4.0
0.77
191
1706
(3019550) Sodium [Moles/volume] in Serum or Plasma
191
1760
2.71
2.59
32.4
15.1
mmol/l
139.6
139.8
0.33
191
1707
(3013707) Erythrocyte sedimentation rate by Westergren method
148
1261
1.66
2.55
4.6
4.1
mm/h
13.0
11.4
0.64
135
1149
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
12
45
2.77
2.50
1.9
1.3
—
1.2
—
0
6
(3004588) Protein electrophoresis panel - Serum or Plasma
22
111
2.10
2.47
1.5
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
14
58
2.52
2.43
5.2
3.4
mmol/l
3.8
3.9
0.18
14
52
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
27
3.44
2.42
1.3
2.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
12
46
2.71
2.40
2.0
1.3
mg/l
32.2
32.6
—
7
37
(3034860) Kappa light chains.free [Mass/volume] in Serum
12
46
2.71
2.40
2.0
1.3
mg/l
38.2
47.1
—
7
36
(40761511) CBC panel - Blood by Automated count
190
1756
2.50
2.38
25.9
12.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
192
1798
2.51
2.37
31.7
14.6
umol/l
86.4
80.5
0.90
192
1798
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
135
1.97
2.35
2.6
1.9
ml/min/173m2
60.3
61.7
0.07
13
52
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
53
361
1.64
2.32
1.6
1.8
mg/l
2.4
1.0
0.95
41
277
(3025941) Bacteria identified in Stool by Culture
18
86
2.20
2.31
1.3
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
18
3.99
2.27
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
29
3.20
2.25
2.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
9
5.66
2.22
2.6
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
55
382
1.61
2.22
4.2
3.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
44
291
1.66
2.15
1.4
1.3
g/l
2.4
2.7
0.73
27
164
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
50
344
1.60
2.09
1.3
1.3
u/ml
0.9
1.4
0.68
12
93
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
97
2.06
2.08
1.5
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.10
2.08
1.4
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
5
10
5.10
2.08
1.6
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
74
559
1.51
2.04
3.0
3.1
ng/l
1601.1
1126.9
0.50
63
464
(3013512) EKG study
71
532
1.52
2.04
4.7
4.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
71
2.20
1.98
1.8
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
176
1604
1.78
1.97
23.5
11.2
ml/min/173m2
76.8
78.2
0.35
165
1292
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
27
3.04
1.96
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
28
2.93
1.88
1.4
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
28
2.93
1.88
2.0
2.7
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
12
4.24
1.83
1.8
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
12
4.24
1.83
1.0
1.4
u/l
49.2
48.0
—
5
7
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
12
4.24
1.83
1.4
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
89
1.99
1.76
1.3
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
181
1.70
1.75
1.6
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
13
3.91
1.72
2.2
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
16
83
2.01
1.70
1.4
1.3
g/l
1.0
1.2
0.19
16
75
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
25
2.86
1.66
1.9
2.0
pg
31.1
34.0
—
7
25
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
20
3.06
1.59
1.3
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
33
2.48
1.55
1.8
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
33
2.48
1.55
1.0
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
27
2.65
1.53
1.1
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
90
742
1.39
1.47
2.3
1.9
pmol/l
91.1
95.0
0.39
53
378
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
22
2.78
1.44
1.3
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
22
2.78
1.44
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
164
1502
1.50
1.41
22.9
13.4
%
39.2
40.4
0.62
96
1030
(3026389) Candida sp identified in Specimen by Organism specific culture
6
23
2.66
1.37
1.3
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
23
2.66
1.37
1.3
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
17
2.99
1.36
1.4
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
17
2.99
1.36
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
17
2.99
1.36
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
44
2.09
1.28
1.3
1.3
—
3.1
—
0
8
(3003327) Ova and parasites identified in Stool by Light microscopy
9
44
2.09
1.28
1.8
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
9
45
2.05
1.25
1.3
1.2
—
2.0
—
0
6
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
19
2.67
1.22
1.4
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
20
2.54
1.16
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
20
2.54
1.16
2.4
4.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
11
58
1.95
1.14
1.9
1.2
g/l
1.1
0.5
0.42
11
53
(3037522) Nuclear Ab [Titer] in Serum
30
212
1.49
1.12
1.4
1.3
titre
506.7
623.5
—
6
46
(3022806) Fractional oxyhemoglobin in Capillary blood
5
21
2.41
1.09
1.8
1.4
%
93.6
90.0
—
5
21
(3021901) Oxygen saturation in Capillary blood
7
32
2.23
1.09
4.0
3.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
60
1.88
1.05
1.9
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
45
349
1.37
1.03
5.3
3.8
ng/l
323.3
221.9
0.23
38
281
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
134
0.51
1.03
1.9
1.8
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
9
49
1.88
1.00
1.3
1.2
—
—
—
0
0
(3012544) pH of Venous blood
25
177
1.47
0.94
4.5
3.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
55
1.86
0.94
1.8
2.3
u/ml
0.4
0.4
—
5
28
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
29
2.10
0.90
2.2
2.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
130
1407
0.78
0.86
34.0
16.2
g/l
332.6
332.9
0.12
130
1401
(4094501)
8
45
1.81
0.85
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
31
1.96
0.85
1.0
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
33
1.84
0.79
2.3
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
26
193
1.40
0.78
1.3
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
34
1.79
0.77
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
50
412
1.28
0.76
3.8
2.7
ug/l
0.9
0.8
0.36
41
272
(3000492) Spirometry study
22
159
1.43
0.76
1.5
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
20
142
1.45
0.76
4.1
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
23
168
1.42
0.75
3.8
3.4
mmol/l
2.2
2.4
0.10
18
131
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
103
928
1.23
0.71
2.7
2.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
26
1.95
0.71
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
26
1.95
0.71
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
110
1.49
0.71
7.3
4.8
mmol/l
0.8
2.3
—
9
77
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
102
1.51
0.70
2.5
2.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
28
1.81
0.66
3.0
2.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
192
1872
1.57
0.63
39.7
18.4
g/l
131.6
137.6
5.74
192
1838
(3026361) Erythrocytes [#/volume] in Blood
192
1872
1.57
0.63
39.4
18.3
e12/l
4.4
4.5
3.93
192
1811
(3010813) Leukocytes [#/volume] in Blood
192
1872
1.57
0.63
39.4
18.3
e9/l
6.9
6.7
1.14
192
1814
(3035941) MCH [Entitic mass]
192
1871
1.58
0.63
39.3
18.2
pg
30.3
30.4
0.82
192
1838
(3024731) MCV [Entitic volume]
192
1871
1.58
0.63
39.3
18.3
fl
91.4
91.3
0.16
192
1839
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
84
749
1.21
0.63
6.2
4.0
ug/l
2.3
2.0
0.28
76
669
(3007461) Platelets [#/volume] in Blood
192
1870
1.60
0.63
39.4
18.3
e9/l
243.9
241.6
0.19
192
1820
(3035285) Chloride [Moles/volume] in Venous blood
5
30
1.68
0.62
3.0
2.4
mmol/l
108.0
105.0
—
5
30
(3041354) Potassium [Moles/volume] in Venous blood
5
30
1.68
0.62
3.0
2.4
mmol/l
4.1
4.1
—
5
30
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
20
0.00
0.60
0.0
1.2
—
68.9
—
0
15
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
11.9
—
0
12
(3004616) Nuclear Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.3
—
59.8
—
0
7
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
0.2
—
0
5
(3000330) Specific gravity of Urine by Test strip
13
89
1.49
0.59
4.8
3.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
1.0
—
0
12
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
283
0.75
0.58
1.0
1.3
u/ml
1.4
10.0
1.94
12
101
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
37
1.64
0.56
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
59
1.55
0.55
2.0
3.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
180
1.31
0.52
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
64
1.43
0.52
1.6
1.3
—
—
—
0
0
(4010399)
18
136
1.36
0.51
1.2
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
49
1.44
0.46
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
49
1.44
0.46
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
49
1.44
0.46
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
148
1.31
0.45
2.3
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
10
69
1.47
0.45
1.8
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
12
87
1.40
0.43
2.8
2.2
%
0.7
0.6
0.53
12
87
(36660697) Celiac disease serology panel - Serum
16
123
1.33
0.42
1.1
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
2.3
—
0
6
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
1.0
—
0
7
(3005033) Fetal Nuchal fold Thickness US
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(4268621)
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
1.0
—
0
9
(3019225) pH of Specimen
19
152
1.28
0.38
11.3
3.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
42
1.44
0.36
1.8
2.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
43
1.41
0.35
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
52
1.36
0.31
7.1
3.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
10
75
1.35
0.31
4.5
2.0
ug/l
379.6
323.7
—
10
68
(3019832) Treponema pallidum Ab [Presence] in Serum
8
106
0.74
0.30
1.9
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
8
109
0.72
0.29
2.1
2.4
e9/l
4.4
4.1
—
8
78
(46235355) HIV 1 and 2 tests - Meaningful Use set
25
214
1.19
0.29
2.2
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
42
378
1.14
0.27
4.9
4.0
kg/l
1.0
1.0
—
9
54
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
64
592
1.12
0.27
4.4
3.7
%
19.5
24.9
2.99
41
270
(3022621) pH of Urine by Test strip
14
113
1.26
0.27
2.9
2.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
75
1.21
0.25
1.1
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
9
75
1.21
0.25
9.7
5.4
mmol/l
24.2
25.4
—
9
70
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
107
1.23
0.22
1.2
1.8
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(4015189)
0
11
0.00
0.21
0.0
3.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(4211845)
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
43
1.17
0.21
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
1.8
—
0
13
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
174
1.17
0.20
2.3
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
118
1.20
0.19
1.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
81
1.25
0.19
1.2
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
53
1.14
0.19
1.3
2.0
—
—
—
0
0
(1002224) Polysomnography panel
7
63
1.12
0.17
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
68
0.73
0.17
3.0
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
8
73
1.10
0.16
1.4
1.9
g/l
1.7
1.5
—
8
60
(1761868) Lipid panel - Serum or Plasma
59
617
0.94
0.12
3.5
3.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
28
299
0.93
0.10
1.1
1.3
iu/ml
10.1
33.3
—
7
102
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.2
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
174
1758
0.92
0.10
6.1
5.3
mmol/l
2.5
2.7
2.08
165
1608
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
63
0.79
0.08
3.0
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
225
0.93
0.08
1.5
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
77
1.04
0.07
1.3
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
112
0.89
0.07
1.1
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
121
1.08
0.04
1.3
2.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
220
1.05
0.03
17.1
7.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
172
1713
1.03
0.01
5.3
4.7
mmol/l
1.4
1.4
2.29
164
1564
(21494755) Public health laboratory ask at order entry panel
13
134
0.97
0.00
1.4
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
166
1659
1.00
0.00
4.8
4.2
mmol/l
1.4
1.3
1.22
155
1501
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
173
1725
1.02
0.00
5.5
4.7
mmol/l
4.3
4.5
2.84
165
1584
(3005322) IgE [Units/volume] in Serum or Plasma
10
102
0.98
0.00
1.3
1.1
u/ml
35.4
193.9
—
10
94
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
46.5
—
0
6
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
54.2
—
0
6
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
91
0.99
0.00
10.1
4.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
72
0.97
0.00
1.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
61
0.98
0.00
1.8
1.5
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
2.6
—
1.3
—
0
5
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.0
—
2.2
—
0
5
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_ENDOCRINE_PANCREAS_EXALLC – Benign neoplasm: Endocrine pancreas
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).